Skip to main content
. Author manuscript; available in PMC: 2014 Apr 1.
Published in final edited form as: Reprod Biomed Online. 2013 Jan 19;26(4):337–344. doi: 10.1016/j.rbmo.2013.01.003

Table 2.

Unadjusted analysis of first IVF cycle characteristics and outcomes for fertility preservation patients and matched controls.

Cases (n = 50) Controls (n = 50) P-value
Baseline oestradiol (pg/ml)a 48.1 (40.9–56.8) 39.2 (35.5–13.4) 0.040
Baseline FSH (mIU/ml)a,b 5.3 (4.3–6.7) 5.7 (5.1–6.4) NS
Baseline AMH (ng/ml)a,c 2.0 (1.6–2.8) 2.5 (1.5–4.1) NS
Baseline antral follicle count 21.1 (17.6–24.7) 19.4 (16.8–22.0) NS
Days of stimulation 9.9 (9.2–10.5) 10.1 (9.6–10.6) NS
Starting gonadotrophin dose (IU) 281.2 (247.5–315.0) 238.8 (204.8–272.7) NS
Total gonadotrophin dose (IU) 3009 (2573–3444) 2556 (2079–3033) NS
Total follicle number 21.6 (18.2–25.1) 22.8 (19.4–26.1) NS
Total follicles >14 mm 11.1 (9.5–12.7) 11.8 (10.6–12.9) NS
Oestradiol at trigger (pg/ml)a 933 (709–1228) 2730 (2453–3044) <0.001
Endometrial thickness at trigger (mm) 9.6 (8.7–10.4) 10.6 (9.8–11.4) NS
No. of oocytes retrieved 12.4 (10.1–14.7) 11.7 (10.1–13.3) NS
No. of oocytes mature (M2) 9.0 (7.4–10.5) 8.9 (7.6–10.2) NS
No. of immature (GV + M1) 2.2 (1.2–3.3) 1.1 (0.6–1.5) 0.030
Maturation rate 74.1 (67.6–80.6) 76.7 (69.2–84.3) NS
No. of 2PN embryos 5.4 (4.1–6.6) 6.0 (4.9–7.2) NS
Fertilization rate 51.6 (43.4–59.5) 69.5 (60.8–78.3) 0.002

Values are mean (95% CI).

a

Geometric mean presented.

b

Data available for 42 cases and 46 controls.

c

Data available for 27 cases and 14 controls.

AMH = anti-Mullerian hormone; NS = not statistically significant.